Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1 with IC50s of 17 nM and 23 nM, respectively.
武汉永璨生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!